Routine Vaccinations Linked with Lower Alzheimer’s Risk

Health & Lifestyle
342

Listen to article (english)

Translate to Spanish or other 102 languages!

Some vaccines are linked to a lower risk of Alzheimer’s. Image for illustration purposes
Some vaccines are linked to a lower risk of Alzheimer’s. Image for illustration purposes

Medical News Today

- Advertisement -
  • Recent research from UTHealth Houston suggests that the administration of some vaccinations, including those for tetanus, diphtheria, pertussis (whooping cough), shingles (herpes zoster), and pneumococcus, are associated with a reduced risk of developing Alzheimer’s disease.
  • Previous research revealed that individuals who had received at least one influenza vaccine had a 40% lower probability of developing Alzheimer’s disease compared to those who had not received any vaccination, leading researchers to investigate other vaccines.
  • These new findings are particularly notable as they point to a practical and accessible way for Alzheimer’s prevention, emphasizing the advantages of routine adult vaccinations.

In a new study whose results appeared in the Journal of Alzheimer’s Disease, researchers found that several vaccines commonly given to adults were similarly linked to a decreased likelihood of developing Alzheimer’s disease.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/routine-vaccinations-linked-with-lower-alzheimers-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas Mission of Mercy Provides Free Dental Care to Low-Income Families
Next article
Avoid Burns in Extreme Heat or When Grilling

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -